191 related articles for article (PubMed ID: 21885276)
21. Triazoles as γ-secretase modulators.
Fischer C; Zultanski SL; Zhou H; Methot JL; Brown WC; Mampreian DM; Schell AJ; Shah S; Nuthall H; Hughes BL; Smotrov N; Kenific CM; Cruz JC; Walker D; Bouthillette M; Nikov GN; Savage DF; Jeliazkova-Mecheva VV; Diaz D; Szewczak AA; Bays N; Middleton RE; Munoz B; Shearman MS
Bioorg Med Chem Lett; 2011 Jul; 21(13):4083-7. PubMed ID: 21616665
[TBL] [Abstract][Full Text] [Related]
22. Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and efficacious gamma-secretase inhibitors (Part II).
Ye XM; Konradi AW; Smith J; Aubele DL; Garofalo AW; Marugg J; Neitzel ML; Semko CM; Sham HL; Sun M; Truong AP; Wu J; Zhang H; Goldbach E; Sauer JM; Brigham EF; Bova M; Basi GS
Bioorg Med Chem Lett; 2010 Jun; 20(12):3502-6. PubMed ID: 20529683
[TBL] [Abstract][Full Text] [Related]
23. Spirocyclic sulfamides as β-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors.
Brodney MA; Barreiro G; Ogilvie K; Hajos-Korcsok E; Murray J; Vajdos F; Ambroise C; Christoffersen C; Fisher K; Lanyon L; Liu J; Nolan CE; Withka JM; Borzilleri KA; Efremov I; Oborski CE; Varghese A; O'Neill BT
J Med Chem; 2012 Nov; 55(21):9224-39. PubMed ID: 22984865
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators.
Pettersson M; Johnson DS; Subramanyam C; Bales KR; am Ende CW; Fish BA; Green ME; Kauffman GW; Lira R; Mullins PB; Navaratnam T; Sakya SM; Stiff CM; Tran TP; Vetelino BC; Xie L; Zhang L; Pustilnik LR; Wood KM; O'Donnell CJ
Bioorg Med Chem Lett; 2012 Apr; 22(8):2906-11. PubMed ID: 22429469
[TBL] [Abstract][Full Text] [Related]
25. Pyridine-derived γ-secretase modulators.
Wan Z; Hall A; Sang Y; Xiang JN; Yang E; Smith B; Harrison DC; Yang G; Yu H; Price HS; Wang J; Hawkins J; Lau LF; Johnson MR; Li T; Zhao W; Mitchell WL; Su X; Zhang X; Zhou Y; Jin Y; Tong Z; Cheng Z; Hussain I; Elliott JD; Matsuoka Y
Bioorg Med Chem Lett; 2011 Aug; 21(16):4832-5. PubMed ID: 21742495
[TBL] [Abstract][Full Text] [Related]
26. Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors.
Zhao Z; Pissarnitski DA; Josien HB; Bara TA; Clader JW; Li H; McBriar MD; Rajagopalan M; Xu R; Terracina G; Hyde L; Song L; Zhang L; Parker EM; Osterman R; Buevich AV
Eur J Med Chem; 2016 Nov; 124():36-48. PubMed ID: 27560281
[TBL] [Abstract][Full Text] [Related]
27. Design of potent inhibitors of human beta-secretase. Part 1.
Freskos JN; Fobian YM; Benson TE; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Moon JB; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G
Bioorg Med Chem Lett; 2007 Jan; 17(1):73-7. PubMed ID: 17046251
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and structure-activity relationship studies of N-arylsulfonyl morpholines as γ-secretase inhibitors.
Li H; Xu R; Cole D; Clader JW; Greenlee WJ; Nomeir AA; Song L; Zhang L
Bioorg Med Chem Lett; 2010 Nov; 20(22):6606-9. PubMed ID: 20933414
[TBL] [Abstract][Full Text] [Related]
29. Design of potent inhibitors of human beta-secretase. Part 2.
Freskos JN; Fobian YM; Benson TE; Moon JB; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G
Bioorg Med Chem Lett; 2007 Jan; 17(1):78-81. PubMed ID: 17049233
[TBL] [Abstract][Full Text] [Related]
30. Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization.
Cumming J; Babu S; Huang Y; Carrol C; Chen X; Favreau L; Greenlee W; Guo T; Kennedy M; Kuvelkar R; Le T; Li G; McHugh N; Orth P; Ozgur L; Parker E; Saionz K; Stamford A; Strickland C; Tadesse D; Voigt J; Zhang L; Zhang Q
Bioorg Med Chem Lett; 2010 May; 20(9):2837-42. PubMed ID: 20347593
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
[TBL] [Abstract][Full Text] [Related]
32. The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice.
Asai M; Hattori C; Iwata N; Saido TC; Sasagawa N; Szabó B; Hashimoto Y; Maruyama K; Tanuma S; Kiso Y; Ishiura S
J Neurochem; 2006 Jan; 96(2):533-40. PubMed ID: 16336629
[TBL] [Abstract][Full Text] [Related]
33. Carbamate-appended N-alkylsulfonamides as inhibitors of gamma-secretase.
Bergstrom CP; Sloan CP; Lau WY; Smith DW; Zheng M; Hansel SB; Polson CT; Corsa JA; Barten DM; Felsenstein KM; Roberts SB
Bioorg Med Chem Lett; 2008 Jan; 18(2):464-8. PubMed ID: 18178084
[TBL] [Abstract][Full Text] [Related]
34. Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 mice.
Goldstein ME; Cao Y; Fiedler T; Toyn J; Iben L; Barten DM; Pierdomenico M; Corsa J; Prasad CV; Olson RE; Li YW; Zaczek R; Albright CF
J Pharmacol Exp Ther; 2007 Oct; 323(1):102-8. PubMed ID: 17640949
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and preliminary evaluation of peptidomimetic inhibitors of human beta-secretase.
Niu Y; Wang Y; Zou X; Yang X; Ma C; Lü Y; Zhou B; Yuan Y; Du G; Xu P
Eur J Med Chem; 2010 May; 45(5):2089-94. PubMed ID: 20153560
[TBL] [Abstract][Full Text] [Related]
36. Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors.
Zhao Z; Pissarnitski DA; Josien HB; Wu WL; Xu R; Li H; Clader JW; Burnett DA; Terracina G; Hyde L; Lee J; Song L; Zhang L; Parker EM
J Med Chem; 2015 Nov; 58(22):8806-17. PubMed ID: 26496070
[TBL] [Abstract][Full Text] [Related]
37. Discovery of gamma-secretase inhibitors efficacious in a transgenic animal model of Alzheimer's disease.
Asberom T; Zhao Z; Bara TA; Clader JW; Greenlee WJ; Hyde LA; Josien HB; Li W; McPhail AT; Nomeir AA; Parker EM; Rajagopalan M; Song L; Wong GT; Zhang L; Zhang Q; Pissarnitski DA
Bioorg Med Chem Lett; 2007 Jan; 17(2):511-6. PubMed ID: 17079141
[TBL] [Abstract][Full Text] [Related]
38. Pyridazine-derived γ-secretase modulators.
Wan Z; Hall A; Jin Y; Xiang JN; Yang E; Eatherton A; Smith B; Yang G; Yu H; Wang J; Ye L; Lau LF; Yang T; Mitchell W; Cai W; Zhang X; Sang Y; Wang Y; Tong Z; Cheng Z; Hussain I; Elliott JD; Matsuoka Y
Bioorg Med Chem Lett; 2011 Jul; 21(13):4016-9. PubMed ID: 21636276
[TBL] [Abstract][Full Text] [Related]
39. Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE).
Boy KM; Guernon JM; Shi J; Toyn JH; Meredith JE; Barten DM; Burton CR; Albright CF; Marcinkeviciene J; Good AC; Tebben AJ; Muckelbauer JK; Camac DM; Lentz KA; Bronson JJ; Olson RE; Macor JE; Thompson LA
Bioorg Med Chem Lett; 2011 Nov; 21(22):6916-24. PubMed ID: 21782431
[TBL] [Abstract][Full Text] [Related]
40. 4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors.
Churcher I; Beher D; Best JD; Castro JL; Clarke EE; Gentry A; Harrison T; Hitzel L; Kay E; Kerrad S; Lewis HD; Morentin-Gutierrez P; Mortishire-Smith R; Oakley PJ; Reilly M; Shaw DE; Shearman MS; Teall MR; Williams S; Wrigley JD
Bioorg Med Chem Lett; 2006 Jan; 16(2):280-4. PubMed ID: 16275079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
